Principal Financial Group’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $6.4M | Buy |
283,284
+21,896
| +8% | +$487K | ﹤0.01% | 1537 |
|
|
2025
Q4 | $6.76M | Buy |
261,388
+6,946
| +3% | +$165K | ﹤0.01% | 1502 |
|
|
2025
Q3 | $6.56M | Sell |
254,442
-16,722
| -6% | -$411K | ﹤0.01% | 1486 |
|
|
2025
Q2 | $6.48M | Buy |
271,164
+3,888
| +1% | +$98K | ﹤0.01% | 1461 |
|
|
2025
Q1 | $6.64M | Buy |
267,276
+9,543
| +4% | +$228K | ﹤0.01% | 1456 |
|
|
2024
Q4 | $4.86M | Buy |
257,733
+10,306
| +4% | +$181K | ﹤0.01% | 1601 |
|
|
2024
Q3 | $3.72M | Sell |
247,427
-9,329
| -4% | -$159K | ﹤0.01% | 1647 |
|
|
2024
Q2 | $7.35M | Sell |
256,756
-8,781
| -3% | -$250K | ﹤0.01% | 1414 |
|
|
2024
Q1 | $7.76M | Buy |
265,537
+2,553
| +1% | +$78.4K | ﹤0.01% | 1420 |
|
|
2023
Q4 | $8.87M | Sell |
262,984
-809
| -0.3% | -$23.7K | 0.01% | 1349 |
|
|
2023
Q3 | $8.09M | Sell |
263,793
-7,558
| -3% | -$272K | 0.01% | 1336 |
|
|
2023
Q2 | $10.9M | Sell |
271,351
-13,048
| -5% | -$539K | 0.01% | 1213 |
|
|
2023
Q1 | $11.6M | Sell |
284,399
-7,078
| -2% | -$282K | 0.01% | 1182 |
|
|
2022
Q4 | $11.3M | Sell |
291,477
-14,763
| -5% | -$718K | 0.01% | 1173 |
|
|
2022
Q3 | $16.3M | Sell |
306,240
-39,503
| -11% | -$2.2M | 0.01% | 909 |
|
|
2022
Q2 | $20.2M | Buy |
345,743
+3,975
| +1% | +$260K | 0.01% | 807 |
|
|
2022
Q1 | $26.1M | Sell |
341,768
-20,468
| -6% | -$1.36M | 0.02% | 750 |
|
|
2021
Q4 | $21.8M | Sell |
362,236
-30,066
| -8% | -$1.66M | 0.01% | 894 |
|
|
2021
Q3 | $22M | Buy |
392,302
+2,826
| +0.7% | +$163K | 0.01% | 868 |
|
|
2021
Q2 | $23.6M | Sell |
389,476
-13,833
| -3% | -$876K | 0.02% | 843 |
|
|
2021
Q1 | $28.3M | Buy |
403,309
+7,827
| +2% | +$559K | 0.02% | 685 |
|
|
2020
Q4 | $23.7M | Sell |
395,482
-25,191
| -6% | -$1.48M | 0.02% | 671 |
|
|
2020
Q3 | $25.3M | Buy |
420,673
+37,402
| +10% | +$2.17M | 0.02% | 561 |
|
|
2020
Q2 | $20.1M | Buy |
383,271
+9,219
| +2% | +$385K | 0.02% | 647 |
|
|
2020
Q1 | $12.5M | Sell |
374,052
-11,334
| -3% | -$471K | 0.01% | 766 |
|
|
2019
Q4 | $17.5M | Buy |
385,386
+11,274
| +3% | +$479K | 0.01% | 902 |
|
|
2019
Q3 | $14.2M | Buy |
374,112
+333,782
| +828% | +$13.3M | 0.01% | 1010 |
|
|
2019
Q2 | $1.75M | Buy |
40,330
+27,442
| +213% | +$1.17M | ﹤0.01% | 1745 |
|
|
2019
Q1 | $490K | Buy |
12,888
+927
| +8% | +$36.2K | ﹤0.01% | 1943 |
|
|
2018
Q4 | $515K | Sell |
11,961
-133
| -1% | -$6.21K | ﹤0.01% | 1913 |
|
|
2018
Q3 | $594K | Buy |
+12,094
| New | +$523K | ﹤0.01% | 1932 |
|
|
2018
Q2 | – | Sell |
-7,250
| Closed | -$226K | – | 2298 |
|
|
2018
Q1 | $226K | Sell |
7,250
-3,986
| -35% | -$142K | ﹤0.01% | 2081 |
|
|
2017
Q4 | $512K | Buy |
+11,236
| New | +$445K | ﹤0.01% | 1955 |
|
|
2017
Q3 | – | Sell |
-5,466
| Closed | -$261K | – | 2236 |
|
|
2017
Q2 | $261K | Buy |
5,466
+270
| +5% | +$12.5K | ﹤0.01% | 2080 |
|
|
2017
Q1 | $237K | Buy |
+5,196
| New | +$225K | ﹤0.01% | 2060 |
|
|
2016
Q2 | – | Sell |
-4,867
| Closed | -$258K | – | 2198 |
|
|
2016
Q1 | $258K | Sell |
4,867
-1,417
| -23% | -$82.9K | ﹤0.01% | 1960 |
|
|
2015
Q4 | $483K | Hold |
6,284
| – | – | ﹤0.01% | 1865 |
|
|
2015
Q3 | $258K | Buy |
6,284
+7
| +0.1% | +$429 | ﹤0.01% | 1975 |
|
|
2015
Q2 | $444K | Sell |
6,277
-331
| -5% | -$26.1K | ﹤0.01% | 1888 |
|
|
2015
Q1 | $587K | Buy |
6,608
+28
| +0.4% | +$2.84K | ﹤0.01% | 1828 |
|
|
2014
Q4 | $583K | Sell |
6,580
-1,021
| -13% | -$96.6K | ﹤0.01% | 1860 |
|
|
2014
Q3 | $737K | Buy |
7,601
+180
| +2% | +$17.5K | ﹤0.01% | 1795 |
|
|
2014
Q2 | $682K | Sell |
7,421
-1,285
| -15% | -$97.8K | ﹤0.01% | 1836 |
|
|
2014
Q1 | $609K | Sell |
8,706
-83
| -0.9% | -$5.64K | ﹤0.01% | 1835 |
|
|
2013
Q4 | $505K | Buy |
8,789
+1,131
| +15% | +$59.5K | ﹤0.01% | 1882 |
|
|
2013
Q3 | $368K | Sell |
7,658
-1,498
| -16% | -$54.6K | ﹤0.01% | 1906 |
|
|
2013
Q2 | $266K | Buy |
+9,156
| New | +$265K | ﹤0.01% | 1979 |
|
Other funds holding PCRX
DPCM
VPM
VCM
